What is Stryker Corporation's earnings per share (EPS)?

Stryker Corporation (SYK) reported diluted earnings per share of $8.40 for fiscal year 2025. This represents a 8.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Stryker Corporation (SYK) Financials

SYK

Trailing 12 months to June 30, 2026

Revenue $25.8B +8.5% YoY

Net Income $3.7B +27.8% YoY

EPS (Diluted) $9.65 +27.8% YoY

Free Cash Flow $4.7B +16.8% YoY

Market Cap $105.6B as of Oct 3, 2026

Price / Sales 4.1x on $25.8B revenue, trailing 12 months to June 30, 2026

Price / Earnings 28.3x on $3.7B net income, trailing 12 months to June 30, 2026

Price / Book 4.4x on $24.0B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 3, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Jul 31, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Jul 31, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SYK SEC filings page.

Stryker Corporation (SYK) reported $25.8B in revenue over the twelve months to Jun 30, 2026, up 8.5% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SYK FY2025 2026-10-03

FY2025 shows fixed-cost leverage: sales growth translated into faster profit growth, while the balance sheet became more debt- and goodwill-heavy.

Revenue grew 11.2% in FY2025 while operating income grew 32.5%, revealing substantial operating leverage. Gross margin stayed near 64.0%, so the wider operating margin points to cost absorption or mix below gross profit rather than a clear change in product-level economics.

Operating cash flow was $5.0B against net income of $3.2B, meaning cash conversion exceeded one-for-one rather than merely tracking reported earnings. Free cash flow reached $4.3B after $761M of capital spending, leaving most operating cash available after reinvestment.

Debt-to-equity rose from 0.6x in FY2024 to 0.7x in FY2025, showing leverage increased even as equity also expanded. Interest expense rose from $396M to $582M while goodwill climbed, so balance-sheet expansion coincided with higher financing cost and greater reliance on goodwill.

Financial Health Signals

Financial Health Score 67/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Stryker Corporation's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Stryker Corporation has an operating margin of 19.5%, meaning the company retains $19 of operating profit per $100 of revenue. This strong profitability earns a score of 86/100, reflecting efficient cost management and pricing power. This is up from 16.3% the prior year.

Growth

Stryker Corporation's revenue grew 11.2% year-over-year to $25.1B, a solid pace of expansion. This earns a growth score of 67/100.

Leverage

Stryker Corporation has a moderate D/E ratio of 0.66. This balance of debt and equity financing earns a leverage score of 35/100.

Liquidity

Stryker Corporation's current ratio of 1.89 indicates adequate short-term liquidity, earning a score of 56/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

Stryker Corporation converts 17.1% of revenue into free cash flow ($4.3B). This strong cash generation earns a score of 80/100.

Returns

Stryker Corporation earns a strong 14.5% return on equity (ROE), meaning it generates $14 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 77/100. This is unchanged from the prior year.

Altman Z-Score Safe

4.13

Stryker Corporation scores 4.13, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($105.6B) relative to total liabilities ($25.4B). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral

4/9

Stryker Corporation passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

1.55x

For every $1 of reported earnings, Stryker Corporation generates $1.55 in operating cash flow ($5.0B OCF vs $3.2B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

8.40x

Stryker Corporation earns $8.40 in operating income for every $1 of interest expense ($4.9B vs $582.0M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$6.6B

YoY+9.4%

QoQ+9.5%

5Y CAGR+8.9%

10Y CAGR+8.8%

Stryker Corporation generated $6.6B in revenue in Q2 2026. This represents an increase of 9.4% from the same quarter a year earlier. Against the prior quarter it is up 9.5%.

EBITDA

$2.1B

YoY+37.5%

QoQ+54.8%

Stryker Corporation's EBITDA was $2.1B in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 37.5% from the same quarter a year earlier. Against the prior quarter it is up 54.8%.

Net Income

$1.3B

YoY+44.3%

QoQ+71.3%

5Y CAGR+16.6%

10Y CAGR+12.9%

Stryker Corporation reported $1.3B in net income in Q2 2026. This represents an increase of 44.3% from the same quarter a year earlier. Against the prior quarter it is up 71.3%.

EPS (Diluted)

$3.30

YoY+44.1%

QoQ+71.0%

5Y CAGR+16.3%

10Y CAGR+12.7%

Stryker Corporation earned $3.30 per diluted share (EPS) in Q2 2026. This represents an increase of 44.1% from the same quarter a year earlier. Against the prior quarter it is up 71.0%.

Cash & Balance Sheet

Free Cash Flow

$1.1B

YoY+14.1%

QoQ+155.2%

5Y CAGR+6.5%

10Y CAGR+10.8%

Stryker Corporation generated $1.1B in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 14.1% from the same quarter a year earlier. Against the prior quarter it is up 155.2%.

Cash & Debt

$3.4B

YoY+42.8%

QoQ+17.8%

5Y CAGR+8.6%

10Y CAGR-0.3%

Stryker Corporation held $3.4B in cash against $14.2B in long-term debt as of Q2 2026.

Dividends Per Share

$0.88

YoY+4.8%

QoQ0.0%

5Y CAGR+6.9%

10Y CAGR+8.8%

Stryker Corporation paid $0.88 per share in dividends in Q2 2026. This represents an increase of 4.8% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

384M

YoY+0.3%

QoQ+0.1%

5Y CAGR+0.3%

10Y CAGR+0.2%

Stryker Corporation had 384M shares outstanding in Q2 2026. This represents an increase of 0.3% from the same quarter a year earlier. Against the prior quarter it is up 0.1%.

Margins & Returns

Gross Margin

68.3%

YoY+4.5pp

QoQ+5.0pp

5Y change+3.7pp

10Y change+3.4pp

Stryker Corporation's gross margin was 68.3% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 4.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 5.0 percentage points.

Operating Margin

25.2%

YoY+6.7pp

QoQ+9.6pp

Stryker Corporation's operating margin was 25.2% in Q2 2026, reflecting core business profitability. This is up 6.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 9.6 percentage points.

Net Margin

19.4%

YoY+4.7pp

QoQ+7.0pp

5Y change+5.6pp

10Y change+6.0pp

Stryker Corporation's net profit margin was 19.4% in Q2 2026, showing the share of revenue converted to profit. This is up 4.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 7.0 percentage points.

Return on Equity

5.3%

YoY+1.1pp

QoQ+2.1pp

5Y change+1.0pp

10Y change+1.1pp

Stryker Corporation's ROE was 5.3% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 1.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.1 percentage points.

Capital Allocation

R&D Spending

$434.0M

YoY+6.6%

QoQ+5.1%

Stryker Corporation invested $434.0M in research and development in Q2 2026. This represents an increase of 6.6% from the same quarter a year earlier. Against the prior quarter it is up 5.1%.

Capital Expenditures

$202.0M

YoY+10.4%

QoQ+21.7%

5Y CAGR+13.8%

10Y CAGR+5.9%

Stryker Corporation invested $202.0M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 10.4% from the same quarter a year earlier. Against the prior quarter it is up 21.7%.

Share Buybacks

Not reported for Q2 2026.

SYK Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SYK quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$25.8B	$25.1B+11.2%	$22.6B+10.2%	$20.5B+11.1%	$18.4B+7.8%	$17.1B+19.2%	$14.4B-3.6%	$14.9B+9.4%	$13.6B+9.3%	$12.4B+9.9%	$11.3B+13.9%	$9.9B+2.8%	$9.7B+7.2%	$9.0B+4.2%	$8.7B+4.2%	$8.3B
Cost of Revenue	N/A	$9.1B+11.0%	$8.2B+9.6%	$7.4B+8.3%	$6.9B+11.9%	$6.1B+16.0%	$5.3B+2.0%	$5.2B+11.3%	$4.7B+9.4%	$4.3B+11.6%	$3.8B+14.3%	$3.3B+0.8%	$3.3B+10.6%	$3.0B+7.9%	$2.8B-1.1%	$2.8B
Gross Profit	$16.8B	$16.1B+11.3%	$14.4B+10.6%	$13.1B+12.8%	$11.6B+5.6%	$11.0B+21.1%	$9.1B-6.6%	$9.7B+8.5%	$8.9B+9.3%	$8.2B+9.0%	$7.5B+13.7%	$6.6B+3.9%	$6.4B+5.6%	$6.0B+2.4%	$5.9B+6.9%	$5.5B
R&D Expenses	N/A	$1.6B+10.7%	$1.5B+5.6%	$1.4B-4.5%	$1.5B+17.7%	$1.2B+25.5%	$984.0M+1.3%	$971.0M+12.6%	$862.0M+9.5%	$787.0M+10.1%	$715.0M+14.4%	$625.0M+1.8%	$614.0M+14.6%	$536.0M+13.8%	$471.0M+1.9%	$462.0M
SG&A Expenses	N/A	$8.7B+12.6%	$7.7B+8.1%	$7.1B+11.4%	$6.4B-0.6%	$6.4B+19.9%	$5.4B+0.1%	$5.4B+5.0%	$5.1B+12.0%	$4.6B+10.0%	$4.1B+14.6%	$3.6B+1.8%	$3.5B+2.3%	$3.5B+3.0%	$3.4B+6.9%	$3.1B
Operating Income	N/A	$4.9B+32.5%	$3.7B-5.1%	$3.9B+36.9%	$2.8B+9.9%	$2.6B+16.2%	$2.2B-18.1%	$2.7B+6.9%	$2.5B+10.4%	$2.3B+5.6%	$2.2B+16.9%	$1.9B+49.4%	$1.2B-0.8%	$1.3B-27.9%	$1.7B+3.3%	$1.7B
EBITDA	N/A	$6.5B+26.3%	$5.1B-2.2%	$5.2B+26.9%	$4.1B+6.8%	$3.9B+16.9%	$3.3B-12.2%	$3.8B+7.3%	$3.5B+11.0%	$3.2B+7.8%	$2.9B+19.4%	$2.5B+33.8%	$1.8B+3.7%	$1.8B-20.7%	$2.2B+2.8%	$2.2B
Interest Expense	N/A	$582.0M+47.0%	$396.0M+11.2%	$356.0M+5.6%	$337.0M0.0%	$337.0M+7.0%	$315.0M+9.8%	$287.0M+8.7%	$264.0M+6.9%	$247.0M+8.3%	$228.0M+111.1%	$108.0M-4.4%	$113.0M+36.1%	$83.0M+31.7%	$63.0M+12.5%	$56.0M
Income Tax	N/A	$1.3B+154.1%	$499.0M-1.8%	$508.0M+56.3%	$325.0M+13.2%	$287.0M-19.2%	$355.0M-25.9%	$479.0M+140.0%	-$1.2B-214.8%	$1.0B+280.7%	$274.0M-7.4%	$296.0M-54.1%	$645.0M+213.1%	$206.0M-49.4%	$407.0M+19.4%	$341.0M
Net Income	$3.7B	$3.2B+8.5%	$3.0B-5.4%	$3.2B+34.2%	$2.4B+18.3%	$2.0B+24.7%	$1.6B-23.2%	$2.1B-41.4%	$3.6B+248.3%	$1.0B-38.1%	$1.6B+14.5%	$1.4B+179.4%	$515.0M-48.8%	$1.0B-22.5%	$1.3B-3.5%	$1.3B
EPS (Basic)	N/A	$8.49+8.0%	$7.86-5.8%	$8.34+33.9%	$6.23+17.8%	$5.29+24.2%	$4.26-23.5%	$5.57-41.4%	$9.50+248.0%	$2.73-38.0%	$4.40+15.2%	$3.82+180.9%	$1.36-48.9%	$2.66-22.0%	$3.41-2.0%	$3.48
EPS (Diluted)	$9.65	$8.40+8.2%	$7.76-5.9%	$8.25+33.7%	$6.17+18.4%	$5.21+24.0%	$4.20-23.4%	$5.48-41.3%	$9.34+248.5%	$2.68-38.4%	$4.35+15.1%	$3.78+182.1%	$1.34-49.0%	$2.63-22.4%	$3.39-1.7%	$3.45
Diluted Shares (Avg)	N/A	387M+0.2%	386M+0.5%	384M+0.4%	382M0.0%	382M+0.5%	380M+0.1%	380M-0.1%	380M+0.1%	380M+0.4%	379M-0.6%	381M-0.5%	383M+0.2%	382M-0.2%	383M-1.7%	390M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-K
Revenue	$6.6B+9.4%	$6.0B+2.6%	$7.2B+11.4%	$6.1B+10.2%	$6.0B+11.1%	$5.9B+11.9%	$6.4B+10.7%	$5.5B+11.9%
Cost of Revenue	$2.1B-4.1%	$2.2B+4.1%	N/A	$2.2B+11.5%	$2.2B+8.7%	$2.1B+11.1%	N/A	$2.0B+12.9%
Gross Profit	$4.5B+17.1%	$3.8B+1.8%	$4.6B+10.9%	$3.9B+9.5%	$3.8B+12.4%	$3.7B+12.3%	$4.2B+12.7%	$3.5B+11.4%
R&D Expenses	$434.0M+6.6%	$413.0M+2.0%	N/A	$410.0M+8.8%	$407.0M+12.1%	$405.0M+10.1%	N/A	$377.0M+6.8%
SG&A Expenses	$2.2B+7.2%	$2.3B-0.8%	N/A	$2.0B+8.0%	$2.1B+13.5%	$2.3B+25.2%	N/A	$1.9B+10.8%
Operating Income	$1.7B+49.1%	$936.0M+11.8%	N/A	$1.1B+4.6%	$1.1B+5.9%	$837.0M-13.9%	N/A	$1.1B+16.5%
EBITDA	$2.1B+37.5%	$1.3B+11.3%	N/A	$1.5B+5.7%	$1.5B+6.8%	$1.2B-9.7%	N/A	$1.5B+22.0%
Interest Expense	$136.0M-14.5%	$142.0M+7.6%	N/A	$157.0M+60.2%	$159.0M+65.6%	$132.0M	N/A	$98.0M
Income Tax	$288.0M+118.2%	$105.0M-4.5%	N/A	$170.0M-18.7%	$132.0M-23.7%	$110.0M-18.5%	N/A	$209.0M+18.1%
Net Income	$1.3B+44.3%	$745.0M+13.9%	$849.0M+55.5%	$859.0M+3.0%	$884.0M+7.2%	$654.0M-17.0%	$546.0M-52.2%	$834.0M+20.5%
EPS (Basic)	$3.32+43.1%	$1.95+14.0%	$2.21+54.5%	$2.25+3.2%	$2.32+6.9%	$1.71-17.4%	$1.43-52.5%	$2.18+19.8%
EPS (Diluted)	$3.30+44.1%	$1.93+14.2%	$2.20+56.0%	$2.22+2.8%	$2.29+7.0%	$1.69-17.6%	$1.41-52.7%	$2.16+20.0%
Diluted Shares (Avg)	386M-0.1%	387M0.0%	N/A	387M+0.3%	386M+0.3%	386M+0.3%	N/A	386M+0.4%

SYK Balance Sheet

SYK quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$47.8B+11.3%	$43.0B+7.7%	$39.9B+8.2%	$36.9B+6.5%	$34.6B+0.9%	$34.3B+13.8%	$30.2B+10.8%	$27.2B+22.7%	$22.2B+8.6%	$20.4B+26.0%	$16.2B-6.0%	$17.3B+12.1%	$15.4B+16.6%	$13.2B+8.7%	$12.1B
Current Assets	$14.8B-0.6%	$14.8B+18.6%	$12.5B+21.8%	$10.3B+2.6%	$10.0B+3.2%	$9.7B-12.2%	$11.1B+13.6%	$9.7B+21.8%	$8.0B+1.7%	$7.9B-1.0%	$7.9B-8.5%	$8.7B+4.2%	$8.3B+2.3%	$8.1B+13.1%	$7.2B
Cash & Equivalents	$4.0B+9.8%	$3.7B+22.9%	$3.0B+61.1%	$1.8B-37.4%	$2.9B0.0%	$2.9B-32.1%	$4.3B+19.9%	$3.6B+42.3%	$2.5B-23.3%	$3.3B-1.9%	$3.4B+88.2%	$1.8B+34.1%	$1.3B-4.0%	$1.4B+54.1%	$905.0M
Short-Term Investments	$89.0M-2.2%	$91.0M+11.0%	$82.0M-2.4%	$84.0M+12.0%	$75.0M-7.4%	$81.0M-8.0%	$88.0M+6.0%	$83.0M-66.9%	$251.0M+269.1%	$68.0M-90.3%	$700.0M-78.2%	$3.2B+21.4%	$2.6B-8.6%	$2.9B+15.0%	$2.5B
Inventory	$5.3B+11.2%	$4.8B-1.4%	$4.8B+21.2%	$4.0B+20.5%	$3.3B-5.2%	$3.5B+17.2%	$3.0B+0.8%	$3.0B+19.9%	$2.5B+21.4%	$2.0B+23.9%	$1.6B+3.2%	$1.6B+11.7%	$1.4B+12.4%	$1.3B-1.4%	$1.3B
Accounts Receivable	$4.0B+1.3%	$4.0B+5.9%	$3.8B+5.6%	$3.6B+18.0%	$3.0B+11.9%	$2.7B-6.6%	$2.9B+24.1%	$2.3B+6.1%	$2.2B+11.7%	$2.0B+18.4%	$1.7B+5.7%	$1.6B+3.6%	$1.5B+6.2%	$1.4B+0.9%	$1.4B
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$19.3B+21.7%	$15.9B+4.0%	$15.2B+2.4%	$14.9B+15.2%	$12.9B+1.1%	$12.8B+40.9%	$9.1B+5.9%	$8.6B+19.5%	$7.2B+12.8%	$6.4B+53.7%	$4.1B-1.2%	$4.2B+8.9%	$3.8B+79.5%	$2.1B+3.4%	$2.1B
Total Liabilities	$25.4B+13.8%	$22.3B+4.8%	$21.3B+5.2%	$20.3B+2.6%	$19.8B-7.0%	$21.2B+22.4%	$17.4B+12.0%	$15.5B+26.9%	$12.2B+12.2%	$10.9B+41.1%	$7.7B-11.0%	$8.7B+36.4%	$6.4B+37.8%	$4.6B+3.3%	$4.5B
Current Liabilities	$7.8B+2.3%	$7.6B-3.9%	$7.9B+25.7%	$6.3B+38.6%	$4.5B-9.8%	$5.0B+14.6%	$4.4B-8.5%	$4.8B+37.9%	$3.5B+10.7%	$3.1B-10.1%	$3.5B-21.5%	$4.5B+67.9%	$2.7B+41.6%	$1.9B+2.0%	$1.8B
Non-Current Liabilities	$17.6B+19.8%	$14.7B+9.9%	$13.4B-4.1%	$14.0B-8.2%	$15.2B-6.2%	$16.2B+25.0%	$13.0B+21.2%	$10.7B+22.4%	$8.7B+12.9%	$7.7B+83.8%	$4.2B+0.2%	$4.2B+13.7%	$3.7B+35.2%	$2.7B+4.2%	$2.6B
Long-Term Debt	$14.9B+21.9%	$12.2B+11.8%	$10.9B-8.1%	$11.9B-4.9%	$12.5B-5.7%	$13.2B+29.3%	$10.2B+20.6%	$8.5B+28.8%	$6.6B-1.4%	$6.7B+107.0%	$3.2B-0.5%	$3.2B+18.5%	$2.7B+56.9%	$1.7B-0.3%	$1.8B
Total Equity	$22.4B+8.7%	$20.6B+11.0%	$18.6B+11.9%	$16.6B+11.7%	$14.9B+13.7%	$13.1B+2.2%	$12.8B+9.2%	$11.7B+17.7%	$10.0B+4.4%	$9.6B+12.2%	$8.5B-1.0%	$8.6B-5.0%	$9.0B+5.2%	$8.6B+11.9%	$7.7B
Retained Earnings	$20.5B+10.5%	$18.5B+10.5%	$16.8B+13.6%	$14.8B+9.5%	$13.5B+8.2%	$12.5B+6.1%	$11.7B+9.1%	$10.8B+19.8%	$9.0B+1.6%	$8.8B+13.5%	$7.8B+3.1%	$7.6B-0.8%	$7.6B+3.9%	$7.3B+13.2%	$6.5B

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-K
Total Assets	$47.9B+3.5%	$46.3B+0.6%	$47.8B+11.3%	$47.1B+7.4%	$46.3B+18.4%	$46.0B+16.8%	$43.0B+7.7%	$43.8B+15.2%
Current Assets	$14.4B+10.9%	$13.3B+2.4%	$14.8B-0.6%	$13.7B-6.6%	$13.0B+11.7%	$13.0B+9.5%	$14.8B+18.6%	$14.7B+32.8%
Cash & Equivalents	$3.4B+42.8%	$2.9B+24.1%	$4.0B+9.8%	$3.3B-15.4%	$2.4B+26.7%	$2.3B-0.4%	$3.7B+22.9%	$3.9B+107.0%
Short-Term Investments	$85.0M-4.5%	$87.0M-2.2%	$89.0M-2.2%	$87.0M+3.6%	$89.0M+7.2%	$89.0M+15.6%	$91.0M+11.0%	$84.0M+10.5%
Inventory	$5.5B+4.4%	$5.4B+6.2%	$5.3B+11.2%	$5.4B+1.5%	$5.3B+4.9%	$5.1B+1.6%	$4.8B-1.4%	$5.3B+8.4%
Accounts Receivable	$3.7B-4.5%	$3.6B-9.8%	$4.0B+1.3%	$3.6B-2.5%	$3.9B+8.2%	$4.0B+14.1%	$4.0B+5.9%	$3.7B+14.0%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$19.6B+2.1%	$19.2B+0.5%	$19.3B+21.7%	$19.3B+17.4%	$19.2B+24.5%	$19.1B+24.4%	$15.9B+4.0%	$16.4B+8.3%
Total Liabilities	$23.9B-4.8%	$23.3B-7.0%	$25.4B+13.8%	$25.3B+6.7%	$25.1B+29.8%	$25.1B+24.0%	$22.3B+4.8%	$23.7B+17.6%
Current Liabilities	$6.7B-8.3%	$6.3B-20.4%	$7.8B+2.3%	$7.4B-3.3%	$7.3B+5.2%	$7.9B+14.0%	$7.6B-3.9%	$7.7B+2.8%
Non-Current Liabilities	$17.3B-3.3%	$17.0B-0.9%	$17.6B+19.8%	$17.9B+11.5%	$17.9B+43.5%	$17.1B+29.2%	$14.7B+9.9%	$16.0B+26.3%
Long-Term Debt	$14.2B-4.3%	$14.2B-1.1%	$14.9B+21.9%	$14.8B+11.4%	$14.8B+46.4%	$14.4B+33.1%	$12.2B+11.8%	$13.3B+28.3%
Total Equity	$24.0B+13.2%	$23.0B+9.8%	$22.4B+8.7%	$21.8B+8.1%	$21.2B+7.2%	$20.9B+9.2%	$20.6B+11.0%	$20.1B+12.5%
Retained Earnings	$21.8B+12.3%	$20.9B+10.7%	$20.5B+10.5%	$20.0B+9.1%	$19.4B+9.3%	$18.9B+9.3%	$18.5B+10.5%	$18.3B+14.9%

SYK Cash Flow Statement

SYK quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$5.5B	$5.0B+18.9%	$4.2B+14.3%	$3.7B+41.4%	$2.6B-19.6%	$3.3B-0.4%	$3.3B+49.6%	$2.2B-16.1%	$2.6B+67.4%	$1.6B-18.6%	$1.9B+95.2%	$981.0M-44.9%	$1.8B-5.5%	$1.9B+13.8%	$1.7B+15.6%	$1.4B
Depreciation & Amortization	N/A	$1.6B+10.1%	$1.4B+6.3%	$1.3B+4.9%	$1.3B+0.5%	$1.3B+18.2%	$1.1B+3.1%	$1.0B+8.1%	$966.0M+12.5%	$859.0M+14.2%	$752.0M+27.5%	$590.0M+0.7%	$586.0M+14.7%	$511.0M+5.1%	$486.0M+1.0%	$481.0M
Stock-Based Compensation	N/A	$243.0M+6.1%	$229.0M+11.7%	$205.0M+22.0%	$168.0M-1.8%	$171.0M+20.4%	$142.0M+11.8%	$127.0M+6.7%	$119.0M+5.3%	$113.0M+16.5%	$97.0M+12.8%	$86.0M+11.7%	$77.0M+1.3%	$76.0M+1.3%	$75.0M0.0%	$75.0M
Capital Expenditures	$823.0M	$761.0M+0.8%	$755.0M+31.3%	$575.0M-2.2%	$588.0M+12.0%	$525.0M+7.8%	$487.0M-25.0%	$649.0M+13.5%	$572.0M-4.3%	$598.0M+22.0%	$490.0M+81.5%	$270.0M+15.9%	$233.0M+19.5%	$195.0M-7.1%	$210.0M-7.1%	$226.0M
Free Cash Flow	$4.7B	$4.3B+22.8%	$3.5B+11.2%	$3.1B+54.0%	$2.0B-25.6%	$2.7B-1.9%	$2.8B+80.9%	$1.5B-24.3%	$2.0B+112.1%	$961.0M-32.6%	$1.4B+100.4%	$711.0M-54.1%	$1.5B-8.4%	$1.7B+16.9%	$1.4B+19.8%	$1.2B
Investing Cash Flow	-$1.4B	-$4.9B-62.2%	-$3.0B-211.9%	-$962.0M+67.1%	-$2.9B-240.4%	-$859.0M+81.7%	-$4.7B-223.1%	-$1.5B+49.1%	-$2.9B-77.1%	-$1.6B+61.5%	-$4.2B-314.3%	$2.0B+204.2%	-$1.9B+15.3%	-$2.2B-201.2%	-$736.0M+65.5%	-$2.1B
Financing Cash Flow	-$3.0B	$113.0M+121.5%	-$525.0M+67.1%	-$1.6B-112.8%	-$749.0M+68.3%	-$2.4B-21400.0%	-$11.0M-466.7%	$3.0M-99.8%	$1.3B+267.4%	-$794.0M-135.2%	$2.3B+284.6%	-$1.2B-294.4%	$629.0M+109.7%	$300.0M+166.8%	-$449.0M-178.9%	-$161.0M
Dividends Paid	$1.3B	$1.3B+5.3%	$1.2B+7.0%	$1.1B+8.4%	$1.1B+10.6%	$950.0M+10.1%	$863.0M+10.9%	$778.0M+10.7%	$703.0M+10.5%	$636.0M+12.0%	$568.0M+9.0%	$521.0M+12.8%	$462.0M+15.2%	$401.0M+23.8%	$324.0M+16.1%	$279.0M
Share Buybacks	N/A	N/A	N/A	N/A	N/A	$0	$0-100.0%	$307.0M+2.3%	$300.0M+30.4%	$230.0M+1669.2%	$13.0M-98.1%	$700.0M+600.0%	$100.0M-68.5%	$317.0M+193.5%	$108.0M-82.6%	$622.0M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-K
Operating Cash Flow	$1.3B+13.5%	$581.0M+132.4%	$2.1B+11.0%	$1.5B+4.5%	$1.1B+75.5%	$250.0M+22.5%	$1.9B+26.4%	$1.5B+40.4%
Depreciation & Amortization	$404.0M+4.4%	$397.0M+10.0%	$416.0M+20.2%	$404.0M+8.9%	$387.0M+9.3%	$361.0M+1.7%	$346.0M	$371.0M+41.6%
Stock-Based Compensation	N/A	$87.0M+3.6%	N/A	N/A	N/A	$84.0M-3.4%	N/A	N/A
Capital Expenditures	$202.0M+10.4%	$166.0M+35.0%	$268.0M+0.8%	$187.0M+10.0%	$183.0M+20.4%	$123.0M-26.3%	$266.0M+83.4%	$170.0M+14.9%
Free Cash Flow	$1.1B+14.1%	$415.0M+226.8%	$1.9B+12.6%	$1.4B+3.8%	$928.0M+92.9%	$127.0M+243.2%	$1.7B+20.4%	$1.3B+44.6%
Investing Cash Flow	-$639.0M-514.4%	-$185.0M+95.5%	-$305.0M-0.7%	-$321.0M+85.2%	-$104.0M+11.1%	-$4.1B-913.7%	-$303.0M-99.3%	-$2.2B-1397.9%
Financing Cash Flow	-$95.0M+90.4%	-$1.5B-159.6%	-$1.1B+39.1%	-$339.0M-112.8%	-$989.0M-2.4%	$2.5B+706.2%	-$1.8B-527.3%	$2.7B+728.7%
Dividends Paid	$337.0M+5.0%	$337.0M+5.3%	$321.0M+5.2%	$322.0M+5.6%	$321.0M+5.2%	$320.0M+5.3%	$305.0M+7.0%	$305.0M+7.0%

Not reported in any period shown, so not listed: Share Buybacks.

SYK Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SYK quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	64.0%0.0pp	63.9%+0.2pp	63.7%+0.9pp	62.8%-1.3pp	64.1%+1.0pp	63.1%-2.0pp	65.1%-0.6pp	65.7%0.0pp	65.7%-0.5pp	66.3%-0.1pp	66.4%+0.7pp	65.7%-1.0pp	66.7%-1.2pp	67.9%+1.7pp	66.2%
Operating Margin	19.5%+3.1pp	16.3%-2.6pp	19.0%+3.6pp	15.4%+0.3pp	15.1%-0.4pp	15.5%-2.7pp	18.2%-0.4pp	18.6%+0.2pp	18.5%-0.8pp	19.2%+0.5pp	18.7%+5.8pp	12.9%-1.0pp	13.9%-6.2pp	20.1%-0.2pp	20.3%
Net Margin	12.9%-0.3pp	13.3%-2.2pp	15.4%+2.7pp	12.8%+1.1pp	11.7%+0.5pp	11.1%-2.8pp	14.0%-12.1pp	26.1%+17.9pp	8.2%-6.3pp	14.5%+0.1pp	14.5%+9.2pp	5.3%-5.8pp	11.2%-3.8pp	15.0%-1.2pp	16.2%
Return on Equity	14.5%0.0pp	14.5%-2.5pp	17.0%+2.8pp	14.2%+0.8pp	13.4%+1.2pp	12.2%-4.0pp	16.3%-14.0pp	30.3%+20.1pp	10.2%-7.0pp	17.3%+0.3pp	16.9%+10.9pp	6.0%-5.1pp	11.1%-4.0pp	15.1%-2.4pp	17.5%
Return on Assets	6.8%-0.2pp	7.0%-1.0pp	7.9%+1.5pp	6.4%+0.6pp	5.8%+1.1pp	4.7%-2.2pp	6.9%-6.2pp	13.1%+8.5pp	4.6%-3.5pp	8.1%-0.8pp	8.9%+5.9pp	3.0%-3.5pp	6.5%-3.3pp	9.8%-1.2pp	11.1%
Current Ratio	1.89-0.1x	1.95+0.4x	1.580.0x	1.63-0.6x	2.20+0.3x	1.93-0.6x	2.51+0.5x	2.02-0.3x	2.29-0.2x	2.50+0.2x	2.27+0.3x	1.95-1.2x	3.14-1.2x	4.34+0.4x	3.92
Debt-to-Equity	0.66+0.1x	0.590.0x	0.59-0.1x	0.71-0.1x	0.84-0.2x	1.01+0.2x	0.80+0.1x	0.72+0.1x	0.660.0x	0.70+0.3x	0.380.0x	0.38+0.1x	0.30+0.1x	0.200.0x	0.23
Asset Turnover	0.530.0x	0.530.0x	0.510.0x	0.500.0x	0.49+0.1x	0.42-0.1x	0.490.0x	0.50-0.1x	0.560.0x	0.55-0.1x	0.61+0.1x	0.560.0x	0.59-0.1x	0.660.0x	0.68
FCF Margin	17.1%+1.6pp	15.4%+0.1pp	15.3%+4.3pp	11.0%-5.0pp	16.0%-3.4pp	19.4%+9.1pp	10.4%-4.6pp	15.0%+7.3pp	7.7%-4.9pp	12.6%+5.4pp	7.1%-8.9pp	16.0%-2.7pp	18.8%+2.0pp	16.7%+2.2pp	14.5%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-K
Gross Margin	68.3%+4.5pp	63.3%-0.5pp	64.5%-0.3pp	63.6%-0.4pp	63.8%+0.8pp	63.8%+0.3pp	64.8%+1.2pp	64.0%-0.3pp
Operating Margin	25.2%+6.7pp	15.6%+1.3pp	N/A	18.7%-1.0pp	18.5%-0.9pp	14.3%-4.3pp	N/A	19.8%+0.8pp
Net Margin	19.4%+4.7pp	12.4%+1.2pp	11.8%+3.4pp	14.2%-1.0pp	14.7%-0.5pp	11.2%-3.9pp	8.5%-11.2pp	15.2%+1.1pp
Return on Equity	5.3%+1.1pp	3.2%+0.1pp	3.8%+1.1pp	3.9%-0.2pp	4.2%0.0pp	3.1%-1.0pp	2.6%-3.5pp	4.1%+0.3pp
Return on Assets	2.7%+0.8pp	1.6%+0.2pp	1.8%+0.5pp	1.8%-0.1pp	1.9%-0.2pp	1.4%-0.6pp	1.3%-1.6pp	1.9%+0.1pp
Current Ratio	2.16+0.4x	2.11+0.5x	1.89-0.1x	1.85-0.1x	1.78+0.1x	1.64-0.1x	1.95+0.4x	1.91+0.4x
Debt-to-Equity	0.59-0.1x	0.62-0.1x	0.66+0.1x	0.680.0x	0.70+0.2x	0.69+0.1x	0.590.0x	0.66+0.1x
Asset Turnover	0.140.0x	0.130.0x	0.150.0x	0.130.0x	0.130.0x	0.130.0x	0.150.0x	0.130.0x
FCF Margin	16.1%+0.7pp	6.9%+4.7pp	26.2%+0.3pp	22.3%-1.4pp	15.4%+6.5pp	2.2%+1.5pp	25.9%+2.1pp	23.7%+5.4pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Stryker Corporation SYK	FY2025	$25.1B	$3.2B	12.9%	$105.6B	67/100
Boston Scientific Corporation BSX	FY2025	$20.1B	$2.9B	14.4%	$61.7B	65/100
Medtronic plc MDT	FY2026	$36.4B	$5K	0.0%	$110.5B	63/100
Edwards Lifesciences Corp EW	FY2025	$6.1B	$1.1B	17.7%	$49.1B	73/100
Zimmer Biomet Holdings, Inc. ZBH	FY2025	$8.2B	$705.1M	8.6%	$16.8B	59/100
Abbott Laboratories ABT	FY2025	$44.3B	$6.5B	14.7%	$167.3B	69/100

Where Stryker Corporation Ranks

Frequently Asked Questions

What is Stryker Corporation's annual revenue?

Stryker Corporation (SYK) reported $25.1B in total revenue for fiscal year 2025. This represents a 11.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Stryker Corporation's revenue growing?

Stryker Corporation (SYK) revenue grew by 11.2% year-over-year, from $22.6B to $25.1B in fiscal year 2025.

Is Stryker Corporation profitable?

Yes, Stryker Corporation (SYK) reported a net income of $3.2B in fiscal year 2025, with a net profit margin of 12.9%.

What is Stryker Corporation's EBITDA?

Stryker Corporation (SYK) had EBITDA of $6.5B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Stryker Corporation have?

As of fiscal year 2025, Stryker Corporation (SYK) had $4.0B in cash and equivalents against $14.9B in long-term debt.

What is Stryker Corporation's gross margin?

Stryker Corporation (SYK) had a gross margin of 64.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Stryker Corporation's operating margin?

Stryker Corporation (SYK) had an operating margin of 19.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Stryker Corporation's net profit margin?

Stryker Corporation (SYK) had a net profit margin of 12.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Stryker Corporation's return on equity (ROE)?

Stryker Corporation (SYK) has a return on equity of 14.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Stryker Corporation's free cash flow?

Stryker Corporation (SYK) generated $4.3B in free cash flow during fiscal year 2025. This represents a 22.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Stryker Corporation's operating cash flow?

Stryker Corporation (SYK) generated $5.0B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Stryker Corporation's total assets?

Stryker Corporation (SYK) had $47.8B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Stryker Corporation's capital expenditures?

Stryker Corporation (SYK) invested $761.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Stryker Corporation spend on research and development?

Stryker Corporation (SYK) invested $1.6B in research and development during fiscal year 2025.

How many shares does Stryker Corporation have outstanding?

Stryker Corporation (SYK) had 383M shares outstanding as of fiscal year 2025.

What is Stryker Corporation's current ratio?

Stryker Corporation (SYK) had a current ratio of 1.89 as of fiscal year 2025, which is generally considered healthy.

What is Stryker Corporation's debt-to-equity ratio?

Stryker Corporation (SYK) had a debt-to-equity ratio of 0.66 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Stryker Corporation's return on assets (ROA)?

Stryker Corporation (SYK) had a return on assets of 6.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Stryker Corporation's P/E ratio?

Stryker Corporation (SYK) trades at 28.3x earnings, its market capitalization divided by net income of $3.7B net income, trailing 12 months to June 30, 2026. The market capitalization is $105.6B as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Stryker Corporation's price-to-sales ratio?

Stryker Corporation (SYK) trades at 4.1x sales, its market capitalization divided by revenue of $25.8B revenue, trailing 12 months to June 30, 2026. The market capitalization is $105.6B as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Stryker Corporation's Altman Z-Score?

Stryker Corporation (SYK) has an Altman Z-Score of 4.13, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Stryker Corporation's Piotroski F-Score?

Stryker Corporation (SYK) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Stryker Corporation's earnings high quality?

Stryker Corporation (SYK) has an earnings quality ratio of 1.55x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Stryker Corporation cover its interest payments?

Stryker Corporation (SYK) has an interest coverage ratio of 8.40x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Stryker Corporation?

Stryker Corporation (SYK) scores 67 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.